Europe Neurotoxins Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Neurotoxins Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Neurotoxins Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Neurotoxins Market Regional Analysis

6.2 Europe Neurotoxins Market Revenue 2021-2028 (US$ Million)

6.3 Europe Neurotoxins Market Forecast Analysis

7. Europe Neurotoxins Market Analysis – by Product Type

7.1 Botox

7.1.1 Overview
7.1.2 Botox: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

7.2 Dysport

7.2.1 Overview
7.2.2 Dysport: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

7.3 Xenomin

7.3.1 Overview
7.3.2 Xenomin: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

8. Europe Neurotoxins Market Analysis – by Application

8.1 Therapeutic and Aesthetic

8.1.1 Overview
8.1.2 Therapeutic and Aesthetic: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

9. Europe Neurotoxins Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

9.2 Specialty Clinics

9.2.1 Overview
9.2.2 Specialty Clinics: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

9.3 Dermatology Clinics

9.3.1 Overview
9.3.2 Dermatology Clinics: Europe Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

10. Europe Neurotoxins Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Neurotoxins Market Breakdown, by Key Country, 2024 and 2028 (%)
10.2.1.1 Europe Neurotoxins Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Neurotoxins Market Breakdown, by Product Type
10.2.1.1.2 UK: Europe Neurotoxins Market Breakdown, by Application
10.2.1.1.3 UK: Europe Neurotoxins Market Breakdown, by End User

10.2.1.2 Germany: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Neurotoxins Market Breakdown, by Product Type
10.2.1.2.2 Germany: Europe Neurotoxins Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Neurotoxins Market Breakdown, by End User

10.2.1.3 France: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Neurotoxins Market Breakdown, by Product Type
10.2.1.3.2 France: Europe Neurotoxins Market Breakdown, by Application
10.2.1.3.3 France: Europe Neurotoxins Market Breakdown, by End User

10.2.1.4 Russia: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Neurotoxins Market Breakdown, by Product Type
10.2.1.4.2 Russia: Europe Neurotoxins Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Neurotoxins Market Breakdown, by End User

10.2.1.5 Italy: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Neurotoxins Market Breakdown, by Product Type
10.2.1.5.2 Italy: Europe Neurotoxins Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Neurotoxins Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Neurotoxins Market Breakdown, by Product Type
10.2.1.6.2 Rest of Europe: Europe Neurotoxins Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Neurotoxins Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AbbVie Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Evolus Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Hugel Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Ipsen SA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Medytox Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merz Pharma GmbH & Co KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Neurotoxins Market

Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)